Northwestern Mutual Wealth Management’s TG Therapeutics TGTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$324K Sell
5,895
-171
-3% -$7K ﹤0.01% 1798
2026
Q1
$202K Sell
6,066
-303
-5% -$9.03K ﹤0.01% 1905
2025
Q4
$190K Sell
6,369
-430
-6% -$14K ﹤0.01% 1896
2025
Q3
$246K Sell
6,799
-285
-4% -$9.39K ﹤0.01% 1719
2025
Q2
$255K Sell
7,084
-941
-12% -$35K ﹤0.01% 1638
2025
Q1
$316K Sell
8,025
-40
-0.5% -$1.35K ﹤0.01% 1492
2024
Q4
$243K Sell
8,065
-11,960
-60% -$343K ﹤0.01% 1573
2024
Q3
$468K Buy
20,025
+725
+4% +$15.8K ﹤0.01% 1326
2024
Q2
$343K Hold
19,300
﹤0.01% 1380
2024
Q1
$294K Buy
19,300
+19,070
+8,291% +$304K ﹤0.01% 1419
2023
Q4
$3.93K Buy
+230
New +$2.67K ﹤0.01% 2929
2023
Q3
Sell
-3,084
Closed -$76.6K 3526
2023
Q2
$76.6K Buy
3,084
+3,079
+61,580% +$79.5K ﹤0.01% 1835
2023
Q1
$75 Buy
+5
New +$76 ﹤0.01% 3270
2022
Q2
Sell
-1,000
Closed -$10K 3468
2022
Q1
$10K Hold
1,000
﹤0.01% 2547
2021
Q4
$19K Hold
1,000
﹤0.01% 2364
2021
Q3
$33K Hold
1,000
﹤0.01% 2048
2021
Q2
$39K Buy
+1,000
New +$39.3K ﹤0.01% 1946
2016
Q4
Sell
-42
Closed 2506
2016
Q3
$0 Buy
+42
New +$270 ﹤0.01% 2331

Other funds holding TGTX

Northwestern Mutual Wealth Management's TGTX Position: Q2 2026 in Review

Northwestern Mutual Wealth Management reduced its TG Therapeutics (TGTX) stake by 2.8% in Q2 2026, selling an estimated $7K and leaving 5,895 shares worth $324K. The position accounts for ﹤0.01% of the portfolio, ranked #1798.

Northwestern Mutual Wealth Management first reported a position in TGTX in Q3 2016 and has held it in 18 quarters since. The position peaked at $468K in Q3 2024. 429 funds tracked by Wall St. Rank hold TGTX as of Q2 2026.

  • Northwestern Mutual Wealth Management held 5,895 shares of TG Therapeutics worth $324K as of Q2 2026.
  • Northwestern Mutual Wealth Management sold 171 TG Therapeutics shares in Q2 2026, an estimated $7K.
  • TG Therapeutics made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q2 2026, its #1798 holding.
  • Northwestern Mutual Wealth Management first reported a position in TG Therapeutics in Q3 2016 and has held it in 18 quarters since.
  • Northwestern Mutual Wealth Management's TG Therapeutics position peaked at $468K in Q3 2024.
  • 429 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.